Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein ReceptorDouglas G. Johns, Harold B. Wood, Tjerk Bueters et al.|Circulation|2023Cited by 141
Leveraging Synergistic Solubility in the Development of a Direct Isolation Process for NemtabrutinibYonggang Chen, E. B. Sirota, Luca Iuzzolino et al.|Organic Process Research & Development|2023Cited by 8